Figure 7From: Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity Ligand Binding to A2A receptor. Top panel: The top-docking pose of cisapride in the human A2A adenosine receptor. (left) Binding interactions are zoomed and detailed (right). Bottom panel: A 2D-ligand interaction map for cisapride binding to the A2A receptor.Back to article page